This guidelines framework document replaces the previous guidance for BHIVA guideline development first agreed in 2007 and last updated in 2020.
The main aims of this framework document are:
To combine the range of improvements introduced into the guideline development process in recent years into a single document
To develop a reference tool for current and future co-authors of guidelines
To summarise the guideline process for all users of the guidance but especially for members of BHIVA, stakeholders, patients and sister agencies
Based on the Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument, the subsequent sections of this policy document demonstrate that BHIVA guidelines are:
Produced to promote clinical care for those living with HIV and reduce the associated morbidity and mortality
Produced by HIV specialists and other healthcare professionals caring for patients with HIV for the benefit of peer healthcare professionals, patients and the public
Produced using a transparent, consistent and reliable development process
Designed to provide recommendations based and graded on the best available evidence
Designed to provide recommendations – strong or weak – weighing up the cost, burden and benefits of treatment or intervention
Designed to provide audit measures for the guideline recommendations
Recognised by the US Department of Health and Human Services (DHHS), European AIDS Clinical Society (EACS) and other international HIV guideline development groups
It is planned that this manual will be updated every 3 years by the BHIVA Guidelines Subcommittee subject to ratification by the Executive Committee.